Hormone-replacement therapy and breast cancer

Area of Science:

• Oncology
• Endocrinology
• Clinical Trials

Background:

• Hormone-replacement therapy (HRT) use is widespread, but its association with breast cancer remains controversial.
• Existing data on HRT and breast cancer risk are largely observational, lacking controlled studies.
• Uncertainty persists regarding specific HRT regimens and their impact on breast cancer development and mortality.

Purpose of the Study:

• To review current clinical data on the relationship between HRT and breast cancer.
• To highlight the limitations of existing research, particularly the lack of controlled data.
• To emphasize the need for prospective controlled trials to inform clinical recommendations.

Main Methods:

• Systematic review of available clinical data on HRT and breast cancer.
• Analysis of observational evidence regarding long-term HRT use and cessation effects.
• Identification of research gaps and limitations in current studies.

Main Results:

• Observational data suggest increased breast cancer risk with HRT use exceeding 10 years.
• Breast cancer risk appears to decrease after HRT cessation.
• Systematic bias and underpowered studies hinder definitive conclusions.

Conclusions:

• Current evidence is insufficient to make firm clinical recommendations on HRT regimens and breast cancer risk.
• Prospective controlled trials are essential for both general and high-risk populations.
• Further research is needed to understand HRT's effect on breast cancer proliferation and mortality.